The new kid on the block(ade) of the IGF-1 receptor

Derek LeRoith; Lee Helman

doi:10.1016/S1535-6108(04)00054-6

The new kid on the block(ade) of the IGF-1 receptor

Derek LeRoith, Lee Helman

Research output: Contribution to journal › Review article › peer-review

80 Scopus citations

Abstract

The insulin-like growth factors (IGF) system, and particularly the IGF-1 receptor, has recently become the subject of major interest in the arena of cancer research. Its involvement in cancer cell growth and survival makes the system an excellent target as potential adjunct therapy to standard chemotherapy.

Original language	English (US)
Pages (from-to)	201-202
Number of pages	2
Journal	Cancer cell
Volume	5
Issue number	3
DOIs	https://doi.org/10.1016/S1535-6108(04)00054-6
State	Published - Mar 2004
Externally published	Yes

ASJC Scopus subject areas

Oncology
Cell Biology
Cancer Research

Access to Document

10.1016/S1535-6108(04)00054-6

Cite this

@article{864ea3c3f3b24f028143a816972fba0c,

title = "The new kid on the block(ade) of the IGF-1 receptor",

abstract = "The insulin-like growth factors (IGF) system, and particularly the IGF-1 receptor, has recently become the subject of major interest in the arena of cancer research. Its involvement in cancer cell growth and survival makes the system an excellent target as potential adjunct therapy to standard chemotherapy.",

author = "Derek LeRoith and Lee Helman",

year = "2004",

month = mar,

doi = "10.1016/S1535-6108(04)00054-6",

language = "English (US)",

volume = "5",

pages = "201--202",

journal = "Cancer cell",

issn = "1535-6108",

publisher = "Cell Press",

number = "3",

}

TY - JOUR

T1 - The new kid on the block(ade) of the IGF-1 receptor

AU - LeRoith, Derek

AU - Helman, Lee

PY - 2004/3

Y1 - 2004/3

N2 - The insulin-like growth factors (IGF) system, and particularly the IGF-1 receptor, has recently become the subject of major interest in the arena of cancer research. Its involvement in cancer cell growth and survival makes the system an excellent target as potential adjunct therapy to standard chemotherapy.

AB - The insulin-like growth factors (IGF) system, and particularly the IGF-1 receptor, has recently become the subject of major interest in the arena of cancer research. Its involvement in cancer cell growth and survival makes the system an excellent target as potential adjunct therapy to standard chemotherapy.

UR - http://www.scopus.com/inward/record.url?scp=1642421788&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=1642421788&partnerID=8YFLogxK

U2 - 10.1016/S1535-6108(04)00054-6

DO - 10.1016/S1535-6108(04)00054-6

M3 - Review article

C2 - 15050909

AN - SCOPUS:1642421788

SN - 1535-6108

VL - 5

SP - 201

EP - 202

JO - Cancer cell

JF - Cancer cell

IS - 3

ER -

The new kid on the block(ade) of the IGF-1 receptor

Abstract

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this